Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil), a generic version of Derma-Smoothe/FS1 Topical Oil, 0.01% (Body Oil), of Hill Dermaceuticals, Inc.

According to IQVIATM sales data for the 12 month period ending August 2018, the Derma-Smoothe/FS Topical Oil, 0.01% market2 achieved annual sales of approximately $14.5 million.

Powered by Capital Market - Live News